Biocept, Inc. is a diagnostics company with commercialized assays for carcinomas and melanoma. The Company leverages its CNSide™ technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with metastatic cancer involving the central nervous system (CNS). Visit www.biocept.com.